Revenue (Quarterly) Chart

View Revenue (Quarterly) for CDXS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (Quarterly) Chart
Start Trial

Historical Revenue (Quarterly) Data

View and export this data back to 2009. Start Trial.
Date Value
June 30, 2026 14.92M
March 31, 2026 15.25M
December 31, 2025 38.92M
September 30, 2025 8.601M
June 30, 2025 15.33M
March 31, 2025 7.543M
December 31, 2024 21.46M
September 30, 2024 12.83M
June 30, 2024 7.979M
March 31, 2024 17.07M
December 31, 2023 26.56M
September 30, 2023 9.277M
June 30, 2023 21.32M
March 31, 2023 12.98M
December 31, 2022 30.38M
September 30, 2022 34.47M
June 30, 2022 38.41M
March 31, 2022 35.34M
December 31, 2021 24.50M
September 30, 2021 36.77M
June 30, 2021 25.45M
March 31, 2021 18.03M
December 31, 2020 21.03M
September 30, 2020 18.38M
June 30, 2020 14.97M
Date Value
March 31, 2020 14.67M
December 31, 2019 18.65M
September 30, 2019 21.91M
June 30, 2019 12.32M
March 31, 2019 15.58M
December 31, 2018 16.07M
September 30, 2018 16.95M
June 30, 2018 13.54M
March 31, 2018 14.04M
December 31, 2017 21.72M
September 30, 2017 9.984M
June 30, 2017 10.35M
March 31, 2017 7.971M
December 31, 2016 9.969M
September 30, 2016 14.87M
June 30, 2016 16.00M
March 31, 2016 7.996M
December 31, 2015 11.59M
September 30, 2015 17.40M
June 30, 2015 6.018M
March 31, 2015 6.798M
December 31, 2014 14.19M
September 30, 2014 7.472M
June 30, 2014 6.57M
March 31, 2014 7.074M

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Quarterly) Range, Past 5 Years

View Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Quarterly) Benchmarks

View Revenue (Quarterly) Benchmarks
Start Trial
Agilent Technologies, Inc. 1.878B
Bio-Rad Laboratories, Inc. 651.00M
Bruker Corp. 838.50M
Azenta, Inc. 161.18M
Danaher Corp. 6.265B